Marc Bifano
Kennedy Krieger Institute(US)
Publications by Year
Research Areas
Hepatitis C virus research, HIV/AIDS drug development and treatment, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, Herpesvirus Infections and Treatments
Most-Cited Works
- → Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in Humans: In Vitro and In Vivo Correlations(2010)228 cited
- → Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1(2010)177 cited
- → Sofosbuvir and Daclatasvir Combination Therapy in a Liver Transplant Recipient With Severe Recurrent Cholestatic Hepatitis C(2013)141 cited
- → Assessment of Pharmacokinetic Interactions of the HCV Ns5A Replication Complex Inhibitor Daclatasvir with Antiretroviral Agents: Ritonavir-Boosted Atazanavir, Efavirenz and Tenofovir(2013)95 cited
- → Scleritodermin A, a Cytotoxic Cyclic Peptide from the Lithistid Sponge Scleritoderma nodosum(2004)74 cited
- → Synthesis, Structure Proof, and Biological Activity of Epothilone Cyclopropanes(2000)72 cited
- → Entecavir Pharmacokinetics, Safety, and Tolerability After Multiple Ascending Doses in Healthy Subjects(2006)68 cited
- → Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation(2012)67 cited
- → The UL8 component of the herpes simplex virus helicase-primase complex stimulates primer synthesis by a subassembly of the UL5 and UL52 components.(1994)53 cited
- → Single-Dose Pharmacokinetics and Safety of Daclatasvir in Subjects with Renal Function Impairment(2014)49 cited